EC
EPALEX Corp
SEC filingPharmaceuticals · Mountain View, CA
Amount raised$1.2Msold at filing
Total offering$3.2M$2M still open
Investors in the raise1count reported to the SEC
FiledNov 10, 2025first sale Oct 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jon SaxeDirector
Brendan MagrabExecutive Officer, Director
Randall MurphyDirector
Didric CedarholmDirector
Michael RogawskiDirector
Executive officers, directors and promoters as listed on the Form D.